LOGIN  |  REGISTER
Chimerix

SHL Telemedicine (NASDAQ: SHLT) Stock Quote

Last Trade: US$6.06 -0.14 -2.26
Volume: 257
5-Day Change: -3.50%
YTD Change: -24.06%
Market Cap: US$99.320M

Latest News From SHL Telemedicine

The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL in advancing the field of telemedicine TEL AVIV, Israel & ZURICH & NEW YORK / Feb 01, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to... Read More
SHL Telemedicine German Operation and BARMER, one of the top health insurance funds in Germany, to present at leading Germany Healthcare Conference TEL AVIV, Israel & ZURICH & NEW YORK / Dec 19, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL " or the " Company "), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce its participation as a... Read More
HealthStocksHub
A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service. TEL AVIV & ZURICH & NEW YORK / Nov 27, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions is pleased... Read More
Pioneering a New Era of Cardiac Care, SHL Telemedicine Established a Comprehensive Network to Broaden Access to Expert Cardiology Services for B2B and Direct-to-Consumer Segments through its SmartHeart® Technology. TEL AVIV, Israel & ZURICH & NEW YORK / Nov 06, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal... Read More
Making Significant Investments in Infrastructure and Technology, SHL Telemedicine Advances its US Direct-to-Consumer Strategy Post Positive Initial Trial Results TEL AVIV, Israel & ZURICH & NEW YORK / Oct 23, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions is pleased to announce that it has made... Read More
Promising outcomes indicate significant reductions in emergency visits and hospital readmissions, alongside reductions in healthcare utilization costs relating to post-MI patient treatment TEL AVIV, Israel & ZURICH & NEW YORK / Sep 26, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, is pleased... Read More
TEL AVIV, Israel & ZURICH & NEW YORK / Sep 21, 2023 / Business Wire / Regulatory News: SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) (“ SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for half-year 2023, emphasizing stable revenues and strategic growth initiatives. In H1 2023, SHL maintained stable revenues while making... Read More
Initial results from the Mayo Clinic HELP-MI and the Imperial College London TELE-ACS trials to be presented at the Vulnerable Plaque and Patient Meeting (VPM) 2023. TEL AVIV, Israel & ZURICH & NEW YORK / Sep 11, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that... Read More
TEL AVIV, Israel , ZURICH and NEW YORK , Sept. 6, 2023 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (NASDAQ: SHLT) (" SHL " or the " Company "), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will issue its Half-year 2023 results before market opens on Thursday, September 21, 2023 . The conference call for investors, journalists, and analysts to... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB